Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Document › Details

BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv.

	Organisation	BioLineRx Ltd. (Nasdaq: BLRX, TASE: BLRX)
	Group	BioLineRx (Group)
	Organisation 2	LifeSci Advisors LLC
	Group	LifeSci (Group)
	Product	BL-8040 (BioLineRx)
	Product 2	AGI-134 (Agalimmune)
	Person	Serlin, Philip A. (BioLineRx 201610– CEO joined 2009 as CFO + COO before Kayote Networks + Tescom Software)

Original document
accessed by [iito] on 2019-08-06

Record changed: 2023-06-05

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for BioLineRx (Group)

[1] BioLineRx Ltd.. (3/23/17). "Press Release: BioLineRx Announces Acquisition of Agalimmune Ltd. to Accelerate Expansion of Immuno-Oncology Pipeline". Tel Aviv....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]